JP2017503764A - 非イオン性x線造影剤の合成における中間体を精製するための代替プロセス - Google Patents
非イオン性x線造影剤の合成における中間体を精製するための代替プロセス Download PDFInfo
- Publication number
- JP2017503764A JP2017503764A JP2016536246A JP2016536246A JP2017503764A JP 2017503764 A JP2017503764 A JP 2017503764A JP 2016536246 A JP2016536246 A JP 2016536246A JP 2016536246 A JP2016536246 A JP 2016536246A JP 2017503764 A JP2017503764 A JP 2017503764A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- bis
- reaction mixture
- dihydroxypropyl
- ptsa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 61
- 239000002872 contrast media Substances 0.000 title abstract description 9
- 230000015572 biosynthetic process Effects 0.000 title description 8
- 238000003786 synthesis reaction Methods 0.000 title description 7
- 239000000543 intermediate Substances 0.000 title description 6
- 229940126062 Compound A Drugs 0.000 claims abstract description 66
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims abstract description 66
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 35
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 28
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical group CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 25
- 239000006227 byproduct Substances 0.000 claims description 22
- 239000011541 reaction mixture Substances 0.000 claims description 22
- 238000005374 membrane filtration Methods 0.000 claims description 21
- 239000002002 slurry Substances 0.000 claims description 19
- 150000001875 compounds Chemical class 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 15
- 238000001728 nano-filtration Methods 0.000 claims description 13
- 239000003377 acid catalyst Substances 0.000 claims description 12
- 238000000746 purification Methods 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- KAEGSAWWVYMWIQ-UHFFFAOYSA-N 5-amino-1-n,3-n-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide Chemical compound NC1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I KAEGSAWWVYMWIQ-UHFFFAOYSA-N 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 230000000850 deacetylating effect Effects 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 7
- 230000003197 catalytic effect Effects 0.000 claims description 4
- 238000005804 alkylation reaction Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 230000002152 alkylating effect Effects 0.000 claims description 2
- 238000006471 dimerization reaction Methods 0.000 claims description 2
- 125000000542 sulfonic acid group Chemical group 0.000 claims 1
- BHCBLTRDEYPMFZ-UHFFFAOYSA-N 5-acetamido-1-n,3-n-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide Chemical compound CC(=O)NC1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I BHCBLTRDEYPMFZ-UHFFFAOYSA-N 0.000 abstract description 19
- 229960004359 iodixanol Drugs 0.000 abstract description 11
- NBQNWMBBSKPBAY-UHFFFAOYSA-N iodixanol Chemical compound IC=1C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C(I)C=1N(C(=O)C)CC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NBQNWMBBSKPBAY-UHFFFAOYSA-N 0.000 abstract description 11
- 238000011143 downstream manufacturing Methods 0.000 abstract description 9
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 229960001025 iohexol Drugs 0.000 abstract description 7
- NTHXOOBQLCIOLC-UHFFFAOYSA-N iohexol Chemical compound OCC(O)CN(C(=O)C)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I NTHXOOBQLCIOLC-UHFFFAOYSA-N 0.000 abstract description 7
- 238000006640 acetylation reaction Methods 0.000 description 22
- 230000021736 acetylation Effects 0.000 description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000002425 crystallisation Methods 0.000 description 13
- 230000008025 crystallization Effects 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 238000000926 separation method Methods 0.000 description 11
- 239000007788 liquid Substances 0.000 description 10
- 238000001035 drying Methods 0.000 description 9
- -1 iodide compound Chemical class 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 230000006196 deacetylation Effects 0.000 description 4
- 238000003381 deacetylation reaction Methods 0.000 description 4
- 239000012065 filter cake Substances 0.000 description 4
- 238000001471 micro-filtration Methods 0.000 description 4
- 239000012466 permeate Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 238000010924 continuous production Methods 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- KFIQRSOQSOSKOM-UHFFFAOYSA-N 1-n,3-n-bis(2,3-dihydroxypropyl)-5-(2-hydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide Chemical compound CC(O)CC1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I KFIQRSOQSOSKOM-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 2
- 230000000397 acetylating effect Effects 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 238000011968 cross flow microfiltration Methods 0.000 description 2
- 230000000447 dimerizing effect Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- YIPGLACOACNFML-UHFFFAOYSA-N 1-n,3-n-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide Chemical compound OCC(O)CNC(=O)C1=C(I)C=C(I)C(C(=O)NCC(O)CO)=C1I YIPGLACOACNFML-UHFFFAOYSA-N 0.000 description 1
- CIUUPJHGWDRPKJ-UHFFFAOYSA-N 2,4,5-triiodobenzene-1,3-dicarboxamide Chemical compound NC(=O)C1=CC(I)=C(I)C(C(N)=O)=C1I CIUUPJHGWDRPKJ-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- NBDAHKQJXVLAID-UHFFFAOYSA-N 5-nitroisophthalic acid Chemical compound OC(=O)C1=CC(C(O)=O)=CC([N+]([O-])=O)=C1 NBDAHKQJXVLAID-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- UFNGEZFIBCOLBF-UHFFFAOYSA-N NC(=O)C1=CC=CC(C(N)=O)=C1I Chemical compound NC(=O)C1=CC=CC(C(N)=O)=C1I UFNGEZFIBCOLBF-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229960000824 iopentol Drugs 0.000 description 1
- IUNJANQVIJDFTQ-UHFFFAOYSA-N iopentol Chemical compound COCC(O)CN(C(C)=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I IUNJANQVIJDFTQ-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
- 229910052808 lithium carbonate Inorganic materials 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
(i)5−アミノ−N,N’−ビス(2,3−ジヒドロキシプロピル)−2,4,6−トリヨードイソフタルアミド(「化合物B」)を無水酢酸/酢酸の混合液と反応させて、第1のスラリーを形成するステップ、
(ii)上記第1のスラリーを約60℃に加熱するステップ、
(iii)酸触媒(好ましくは、パラ−トルエンスルホン酸(PTSA))を、反応温度が約65〜85℃の温度範囲に維持されるような速度で、上記スラリーに添加するステップ、
(iv)脱アセチル化剤をステップ(iii)の反応混合物に添加して、化合物Aを含む反応混合物を形成するステップ、
(v)化合物Aを含むステップ(iv)の反応混合物を精製するステップを含み、上記精製ステップが、
(vi)化合物Aを含むステップ(iv)の反応混合物を分離システムで濾過して、第2のスラリー及び液体を生成するステップ、
(vii)ステップ(vi)の第2のスラリーを収集し、ステップ(v)を繰り返すステップ、
(viii)ステップ(vi)の液体を収集し、それをメンブレン濾過システムで濾過するステップ、
(ix)ステップ(viii)の濾過残渣を収集し、ステップ(v)を繰り返すステップ、及び
(x)ステップ(v)〜(ix)を連続的に繰り返すステップ
を含むプロセスを提供する。
(i)5−アミノ−N,N’−ビス(2,3−ジヒドロキシプロピル)−2,4,6−トリヨードイソフタルアミド(「化合物B」)を無水酢酸/酢酸の混合液と反応させて、スラリーを形成するステップ、
(ii)上記スラリーを約60℃に加熱するステップ、
(iii)酸触媒(好ましくは、パラ−トルエンスルホン酸(PTSA))を、反応温度が約65〜85℃の温度範囲に維持されるような速度で、上記スラリーに添加するステップ、
(iv)脱アセチル化剤をステップ(iii)の反応混合物に添加して、化合物Aを含む反応混合物を形成するステップ、
(v)化合物Aを含むステップ(iv)の反応混合物を精製するステップを含み、上記精製ステップが、
(vi)化合物Aを含むステップ(iv)の反応混合物をメンブレン濾過システムで濾過するステップ、
(vii)ステップ(vi)の濾過残渣を収集し、ステップ(v)を繰り返すステップ、及び
(viii)ステップ(v)〜(vii)を連続的に繰り返すステップを含むプロセスを提供する。
図1に示されている代替プロセス1は、所望の化合物Aを含む溶液のpH及び粘性を低減する簡便な析出ステップを含む。5−アセトアミド−N,N’−ビス(2,3−ジヒドロキシプロピル)−2,4,6−トリヨードイソフタルアミド(「化合物A」)の粒子サイズ及び粒子分布は、濾過ケーキを取り扱うことにならないため、確立されているアセチル化プロセスほど重要ではない。
代替プロセス2では、図2に示されているように、脱アセチル化後の粗反応溶液を反応器に供給し、pH>11に維持して、5−アセトアミド−N,N’−ビス(2,3−ジヒドロキシプロピル)−2,4,6−トリヨードイソフタルアミド(「化合物A」)の溶解を維持した。イオヘキソール及びイオジキサノールの合成にそのまま使用するための溶液を調製するためには、溶液中の水を、メタノール等の溶媒に置換しなければならず、次いでそれを、随意に、溶媒及び高pHに耐える適切なカットオフを有する膜を備えるナノ濾過システムで、2−メトキシエタノールに置換してもよい。塩及び低分子量副産物は、透過液に収集される。5−アセトアミド−N,N’−ビス(2,3−ジヒドロキシプロピル)−2,4,6−トリヨードイソフタルアミド(「化合物A」)は、濾過残渣に収集される。ナノ濾過システムを使用することにより、反応器へとフィードバックされる前に、5−アセトアミド−N,N’−ビス(2,3−ジヒドロキシプロピル)−2,4,6−トリヨードイソフタルアミド(「化合物A」)の濃度調整が可能になる。濃度及びプロセス時間を調整することにより、生産能力及び投資コスト/運転コストを最適化することができる。代替プロセス2は、塩のレベルが、化合物A溶液の1.5重量%NMT、副産物のレベルが、2.0面積%NMTとなるまで、連続的に実施される。
Claims (9)
- 以下のステップ:
(i)5−アミノ−N,N’−ビス(2,3−ジヒドロキシプロピル)−2,4,6−トリヨードイソフタルアミド(「化合物B」)を無水酢酸/酢酸の混合物と反応させて、スラリーを形成するステップ、
(ii)スラリーを約60℃に加熱するステップ、
(iii)酸触媒を、反応温度が約65〜85℃の温度範囲に維持されるような速度で、スラリーに添加するステップ、
(iv)脱アセチル化剤を、ステップ(iii)の反応混合物に添加して、化合物Aを含む反応混合物を形成するステップ、
(v)化合物Aを含むステップ(iv)の反応混合物を精製するステップを含み、精製ステップが、
(vi)化合物Aを含むステップ(iv)の反応混合物をメンブレン濾過システムで濾過するステップ、
(vii)ステップ(vi)の濾過残渣を収集し、ステップ(v)を繰り返すステップ、及び
(viii)ステップ(v)〜(vii)を連続的に繰り返すステップ
を含む方法。 - メンブレン濾過システムが、ナノ濾過システムを含む、請求項1に記載の方法。
- 塩のレベルが、化合物A溶液の1.5重量%以下(NMT)、副産物のレベルが、2.0面積%NMTになるまで、ステップ(viii)が繰り返される、請求項1又は2に記載の方法。
- 化合物Aを含むステップ(iv)の反応混合物をアルキル化するステップを更に含む、請求項1乃至3のいずれか1項に記載の方法。
- 化合物Aを含むステップ(iv)の反応混合物をビス−アルキル化又は二量体化するステップを更に含む、請求項1乃至3のいずれか1項に記載の方法。
- 酸触媒が、スルホン酸である、請求項1乃至5のいずれか1項に記載の方法。
- 酸触媒が、パラ−トルエンスルホン酸(PTSA)である、請求項6に記載の方法。
- PTSAが、固形物として触媒量で添加される、請求項7に記載の方法。
- PTSAが、少容積の無水酢酸に溶解されているPTSAの溶液として、触媒量で添加される、請求項7に記載の方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361912807P | 2013-12-06 | 2013-12-06 | |
US61/912,807 | 2013-12-06 | ||
US201461969959P | 2014-03-25 | 2014-03-25 | |
US61/969,959 | 2014-03-25 | ||
PCT/EP2014/076873 WO2015082718A1 (en) | 2013-12-06 | 2014-12-08 | Alternative process for the purification of an intermediate in the synthesis of non-ionic x-ray contrast agents |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017503764A true JP2017503764A (ja) | 2017-02-02 |
JP6506759B2 JP6506759B2 (ja) | 2019-04-24 |
Family
ID=52117868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016536246A Active JP6506759B2 (ja) | 2013-12-06 | 2014-12-08 | 非イオン性x線造影剤の合成における中間体を精製するための代替プロセス |
Country Status (7)
Country | Link |
---|---|
US (1) | US9695113B2 (ja) |
EP (1) | EP3077367B1 (ja) |
JP (1) | JP6506759B2 (ja) |
CN (1) | CN105793235B (ja) |
ES (1) | ES2683712T3 (ja) |
PT (1) | PT3077367T (ja) |
WO (1) | WO2015082718A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105873898B (zh) * | 2013-12-06 | 2019-06-25 | 通用电气医疗集团股份有限公司 | 纯化在非离子x-射线造影剂的合成中的中间体的供选方法 |
CN105669488A (zh) * | 2016-01-11 | 2016-06-15 | 浙江海洲制药有限公司 | X-ct造影剂含碘中间体母液的预处理及中间体回收方法 |
CN114853625A (zh) * | 2022-03-31 | 2022-08-05 | 海南普利制药股份有限公司 | 一种工业化生产碘海醇中间体的方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5321137A (en) * | 1976-06-11 | 1978-02-27 | Serukapeto | Xxray contrast medium |
CN1132743A (zh) * | 1995-11-20 | 1996-10-09 | 江苏省原子医学研究所 | 一种碘海醇的制备方法 |
EP2277859A1 (en) * | 2009-07-21 | 2011-01-26 | GE Healthcare AS | Acetylation using reduced concentration of acetic acid anhydride for synthesizing non-ionic X-ray contrast agents |
EP2277851A1 (en) * | 2009-07-21 | 2011-01-26 | GE Healthcare AS | Acetylation using reduced volume of acetic acid anhydride for synthesizing non-ionic X-ray contrast agents |
US20110021822A1 (en) * | 2009-07-21 | 2011-01-27 | Ge Healthcare As | continuous deacetylation and purification process in synthesis of non-ionic x-ray contrast agents |
US20110021821A1 (en) * | 2009-07-21 | 2011-01-27 | Ge Healthcare As | Continuous acetylation process in synthesis of non-ionic x-ray contrast agents |
US20110021828A1 (en) * | 2009-07-21 | 2011-01-27 | Ge Healthcare As | Recovering unreacted intermediate from desalinated and desolventized dimerisation reaction mixture by ultrafiltration |
US20110021823A1 (en) * | 2009-07-21 | 2011-01-27 | Ge Healthcare As | Processing crude iodixanol mixture by nanofiltration |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811581A (en) * | 1994-08-04 | 1998-09-22 | Dibra S.P.A. | Process for the purification of opacifying contrast agents |
US5840967A (en) * | 1996-08-29 | 1998-11-24 | Nycomed Imaging As | Process for the preparation of contrast agents |
GB9618055D0 (en) * | 1996-08-29 | 1996-10-09 | Nycomed Imaging As | Process |
US20030236407A1 (en) * | 2002-02-28 | 2003-12-25 | Schering Ag | Perfluoroalkyl group-containing micelle-forming triiodoaromatic compounds, process for their production and their use as contrast media |
WO2007073202A1 (en) * | 2005-12-19 | 2007-06-28 | Ge Healthcare As | Purification process of iodixanol |
KR20100033405A (ko) * | 2007-07-12 | 2010-03-29 | 지이 헬스케어 에이에스 | 조영제 |
US7754920B1 (en) * | 2009-07-21 | 2010-07-13 | Ge Healthcare As | Solvent reduction in crystallisation of intermediate for non-ionic X-ray contrast agents |
JP2012051850A (ja) * | 2010-09-02 | 2012-03-15 | Terumo Corp | 経カテーテル動脈化学塞栓術用抗癌剤溶液 |
ES2680019T3 (es) * | 2010-12-21 | 2018-09-03 | Ge Healthcare As | Desalinización de una composición que comprende un agente de contraste |
-
2014
- 2014-12-08 CN CN201480066351.0A patent/CN105793235B/zh active Active
- 2014-12-08 JP JP2016536246A patent/JP6506759B2/ja active Active
- 2014-12-08 EP EP14814792.9A patent/EP3077367B1/en active Active
- 2014-12-08 US US15/100,818 patent/US9695113B2/en active Active
- 2014-12-08 ES ES14814792.9T patent/ES2683712T3/es active Active
- 2014-12-08 WO PCT/EP2014/076873 patent/WO2015082718A1/en active Application Filing
- 2014-12-08 PT PT14814792T patent/PT3077367T/pt unknown
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5321137A (en) * | 1976-06-11 | 1978-02-27 | Serukapeto | Xxray contrast medium |
CN1132743A (zh) * | 1995-11-20 | 1996-10-09 | 江苏省原子医学研究所 | 一种碘海醇的制备方法 |
EP2277859A1 (en) * | 2009-07-21 | 2011-01-26 | GE Healthcare AS | Acetylation using reduced concentration of acetic acid anhydride for synthesizing non-ionic X-ray contrast agents |
EP2277851A1 (en) * | 2009-07-21 | 2011-01-26 | GE Healthcare AS | Acetylation using reduced volume of acetic acid anhydride for synthesizing non-ionic X-ray contrast agents |
US20110021822A1 (en) * | 2009-07-21 | 2011-01-27 | Ge Healthcare As | continuous deacetylation and purification process in synthesis of non-ionic x-ray contrast agents |
US20110021821A1 (en) * | 2009-07-21 | 2011-01-27 | Ge Healthcare As | Continuous acetylation process in synthesis of non-ionic x-ray contrast agents |
US20110021828A1 (en) * | 2009-07-21 | 2011-01-27 | Ge Healthcare As | Recovering unreacted intermediate from desalinated and desolventized dimerisation reaction mixture by ultrafiltration |
US20110021823A1 (en) * | 2009-07-21 | 2011-01-27 | Ge Healthcare As | Processing crude iodixanol mixture by nanofiltration |
Also Published As
Publication number | Publication date |
---|---|
WO2015082718A1 (en) | 2015-06-11 |
EP3077367B1 (en) | 2018-07-11 |
CN105793235A (zh) | 2016-07-20 |
CN105793235B (zh) | 2019-08-23 |
US20160289174A1 (en) | 2016-10-06 |
JP6506759B2 (ja) | 2019-04-24 |
US9695113B2 (en) | 2017-07-04 |
ES2683712T3 (es) | 2018-09-27 |
EP3077367A1 (en) | 2016-10-12 |
PT3077367T (pt) | 2018-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1150943B1 (en) | Preparation of iodixanol | |
JP5048490B2 (ja) | イオジキサノールの製造 | |
EP1960349B1 (en) | Purification of iodixanol | |
EP1966110B1 (en) | Purification process of iodixanol | |
US10011560B2 (en) | Alternative process for the purification of an intermediate in the synthesis of non-ionic X-ray contrast agents | |
JP6506759B2 (ja) | 非イオン性x線造影剤の合成における中間体を精製するための代替プロセス | |
EP2281811A1 (en) | A continuous deacetylation and purification process in the synthesis of non-ionic X-ray contrast agents | |
JP2019206536A (ja) | 非イオン性x線造影剤の合成における代替アセチル化方法 | |
EP2281804A1 (en) | A continuous process of preparing 5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide, an intermediate for synthesizing non-ionic X-ray contrast agents | |
KR20110009053A (ko) | 비-이온성 x-선 조영제의 제조에서 아미노이소프탈산 비스아미드 관련 불순물을 감소시키는 방법 | |
CN115093342A (zh) | 一种工业化生产碘佛醇的方法 | |
CA2710573A1 (en) | A continuous process of preparing intermediate for non-ionic x-ray contrast agents | |
CA2710102A1 (en) | Improvements in crystallization of an intermediate for synthesizing non-ionic x-ray contrast agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20171127 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20181022 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20181030 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190130 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190305 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190329 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6506759 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D02 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |